Page 119 - Recognizing axial spondyloarthritis - Janneke de Winter

degree relatives. Nevertheless, we found no differences between these groups in demographics, history of SpA symptoms, disease activity, clinical examination findings, laboratory test results, and imaging abnormalities (Table 3).
Table 1. Clinical characteristics, laboratory and imaging results of the FDRs of those fulfilling and not fulfilling the ASAS axSpA and/or ESSG classification criteria
THE PRE-SPA COHORT
Study population
(n= 51)
25 (49)
50 (98) 25.2 (5.1) 23.53 (3.16) 26 (51)
14 (28) 0 (0)
29 (56.9) 11 (21.6) 2 (3.9)
5 (9.8)
20 (40) 1 (2)
0 (0)
0 (0)
2 (4)
1 (2) 0 (0)
1 (2)
Fulfilling the ASAS axSpA and/or ESSG criteria
Fulfilling vs not fulfilling the ASAS axSpA and/or ESSG criteria
p-value 0.433
0.157 0.595 0.935 0.695 0.973 -
<0.001 <0.001 0.614 0.001
0.160 0.480 -
-
0.043
0.157 -
0.157
Demographics
Male gender
Caucasian
Age, years, mean (SD) BMI, kg/m2, mean (SD) HLA-B27 positive Current smoker
Use of DMARD, TNF inhibitor
or corticosteroids ever History
Axial disease
Back pain Inflammatory back pain Buttock pain
Good response to NSAIDs
Peripheral disease Arthralgia (past/ present)
Peripheral arthritis (past/present) Enthesitis(past/ present)
Dactylitis (past/ present)
Extra-articular disease Psoriasis (past/ present)
IBD (past/present) Urethritis/diarrhoea (past/present)
Uveitis (past/present)
Yes (n=17)
7 (41)
16 (94) 25.8 (5.2) 23.57 (3.72) 8 (47)
4 (24)
0 (0)
17 (100) 11 (65) 1 (6)
5 (29)
9 (53) 0 (0) 0 (0) 0 (0)
2 (12)
1 (6) 0 (0)
1 (6)
No (n=34)
18 (53)
34 (100) 24.9 (5) 23.51 (2.89) 18 (53)
10 (29) 0 (0)
12 (35) 0 (0)
1 (3)
0 (0)
11 (32) 1 (3)
0 (0)
0 (0)
0 (0)
0 (0) 0 (0)
0 (0)
Table 1 continues
117
SEVEN